This inventor holds 6 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignee: Novartis Ag. Active years: 2010-2017.
Location History:
- Hirsingue, FR (2010 - 2012)
- Basel, CH (2017)
Company Filing History:
Years Active: 2010-2017
Title: Innovations of Dominique Grimler
Introduction
Dominique Grimler is a notable inventor based in Hirsingue, France. He has made significant contributions to the field of pharmaceuticals, holding a total of six patents. His work focuses on chemical processes and novel pharmaceutical compounds.
Latest Patents
Among his latest patents is a chemical process for preparing spiroindolones and intermediates thereof. This invention relates to processes and intermediates useful for the manufacture of spiroindolone compounds, including (1'R,3′S)-5,7′-dichloro-6′-fluoro-3′-methyl-2′,3′,4′,9′-tetrahydrospiro[indoline-3,1′-pyrido[3,4-b]indol]-2-one and its salts, hydrates, and solvates. Another significant patent involves optical isomers of an iloperidone metabolite, which pertains to novel isomers of a metabolite of Iloperidone, their preparation, and their use as pharmaceuticals and pharmaceutical compositions.
Career Highlights
Dominique Grimler is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative pharmaceutical solutions that address various medical needs.
Collaborations
Throughout his career, Grimler has collaborated with esteemed colleagues such as Gottfried Sedelmeier and Murat Acemoglu. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Dominique Grimler's contributions to the field of pharmaceuticals through his innovative patents highlight his expertise and commitment to advancing medical science. His work continues to impact the industry positively.